vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and SWK Holdings Corp (SWKH). Click either name above to swap in a different company.
SWK Holdings Corp is the larger business by last-quarter revenue ($8.7M vs $7.8M, roughly 1.1× CRYO CELL INTERNATIONAL INC). On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -29.7%). SWK Holdings Corp produced more free cash flow last quarter ($26.8M vs $1.2M). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -12.5%).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
SWK Holdings Corp is a specialty finance firm focused on the healthcare and life sciences sectors. It provides tailored financing solutions including royalty monetization, structured debt, and asset-backed lending to biotech, pharmaceutical, medical device and diagnostic companies, with its core market centered in North America.
CCEL vs SWKH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $8.7M |
| Net Profit | $-3.8M | $-19.4M |
| Gross Margin | 77.9% | — |
| Operating Margin | -50.6% | 9.9% |
| Net Margin | -48.7% | — |
| Revenue YoY | -2.3% | -29.7% |
| Net Profit YoY | -105.1% | -430.2% |
| EPS (diluted) | $-0.46 | $-1.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $8.7M | ||
| Q3 25 | $7.8M | $10.9M | ||
| Q2 25 | $7.9M | $10.1M | ||
| Q1 25 | $8.0M | $11.8M | ||
| Q4 24 | $8.0M | $12.4M | ||
| Q3 24 | $8.1M | $10.4M | ||
| Q2 24 | $8.0M | $10.8M | ||
| Q1 24 | $7.9M | $11.4M |
| Q4 25 | $-3.8M | $-19.4M | ||
| Q3 25 | $749.4K | $8.8M | ||
| Q2 25 | $355.8K | $3.5M | ||
| Q1 25 | $282.9K | $4.5M | ||
| Q4 24 | $-1.9M | $5.9M | ||
| Q3 24 | $1.1M | $3.5M | ||
| Q2 24 | $655.8K | $3.7M | ||
| Q1 24 | $556.2K | $468.0K |
| Q4 25 | 77.9% | — | ||
| Q3 25 | 77.0% | — | ||
| Q2 25 | 76.6% | — | ||
| Q1 25 | 75.1% | — | ||
| Q4 24 | 78.4% | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | 73.7% | — |
| Q4 25 | -50.6% | 9.9% | ||
| Q3 25 | 24.3% | 61.3% | ||
| Q2 25 | 18.8% | 46.1% | ||
| Q1 25 | 13.3% | 68.6% | ||
| Q4 24 | -1.5% | 44.7% | ||
| Q3 24 | 17.2% | 39.2% | ||
| Q2 24 | 17.3% | 8.3% | ||
| Q1 24 | 10.5% | 9.5% |
| Q4 25 | -48.7% | — | ||
| Q3 25 | 9.6% | 80.7% | ||
| Q2 25 | 4.5% | 35.2% | ||
| Q1 25 | 3.5% | 38.4% | ||
| Q4 24 | -23.2% | 47.5% | ||
| Q3 24 | 13.0% | 33.3% | ||
| Q2 24 | 8.2% | 33.9% | ||
| Q1 24 | 7.1% | 4.1% |
| Q4 25 | $-0.46 | $-1.59 | ||
| Q3 25 | $0.09 | $0.72 | ||
| Q2 25 | $0.04 | $0.29 | ||
| Q1 25 | $0.03 | $0.37 | ||
| Q4 24 | $-0.23 | $0.47 | ||
| Q3 24 | $0.13 | $0.28 | ||
| Q2 24 | $0.08 | $0.30 | ||
| Q1 24 | $0.07 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $42.8M |
| Total DebtLower is stronger | $8.4M | $33.0M |
| Stockholders' EquityBook value | $-18.6M | $235.1M |
| Total Assets | $61.7M | $272.4M |
| Debt / EquityLower = less leverage | — | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $42.8M | ||
| Q3 25 | $3.2M | $10.2M | ||
| Q2 25 | $4.4M | $8.0M | ||
| Q1 25 | $3.5M | $29.8M | ||
| Q4 24 | $3.5M | $5.9M | ||
| Q3 24 | $2.1M | $17.2M | ||
| Q2 24 | $1.5M | $5.5M | ||
| Q1 24 | $979.6K | $5.5M |
| Q4 25 | $8.4M | $33.0M | ||
| Q3 25 | $8.4M | $33.0M | ||
| Q2 25 | $8.4M | $33.0M | ||
| Q1 25 | $8.5M | $33.0M | ||
| Q4 24 | $8.5M | $33.0M | ||
| Q3 24 | $8.5M | $33.0M | ||
| Q2 24 | $8.5M | $33.0M | ||
| Q1 24 | $8.6M | $33.0M |
| Q4 25 | $-18.6M | $235.1M | ||
| Q3 25 | $-14.8M | $254.2M | ||
| Q2 25 | $-15.6M | $246.5M | ||
| Q1 25 | $-14.7M | $292.7M | ||
| Q4 24 | $-13.2M | $288.7M | ||
| Q3 24 | $-9.6M | $283.4M | ||
| Q2 24 | $-10.7M | $282.8M | ||
| Q1 24 | $-10.3M | $279.9M |
| Q4 25 | $61.7M | $272.4M | ||
| Q3 25 | $63.2M | $289.4M | ||
| Q2 25 | $64.4M | $285.7M | ||
| Q1 25 | $64.4M | $331.3M | ||
| Q4 24 | $64.7M | $332.2M | ||
| Q3 24 | $62.9M | $321.3M | ||
| Q2 24 | $62.6M | $321.0M | ||
| Q1 24 | $61.7M | $322.0M |
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $27.3M |
| Free Cash FlowOCF − Capex | $1.2M | $26.8M |
| FCF MarginFCF / Revenue | 15.5% | 308.1% |
| Capex IntensityCapex / Revenue | 0.9% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | $43.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $27.3M | ||
| Q3 25 | $2.5M | $906.0K | ||
| Q2 25 | $707.0K | $7.8M | ||
| Q1 25 | $954.1K | $8.3M | ||
| Q4 24 | $2.2M | $23.0M | ||
| Q3 24 | $2.4M | $6.3M | ||
| Q2 24 | $1.8M | $5.4M | ||
| Q1 24 | $-356.9K | $4.4M |
| Q4 25 | $1.2M | $26.8M | ||
| Q3 25 | $2.5M | $557.0K | ||
| Q2 25 | $644.6K | $7.7M | ||
| Q1 25 | $892.0K | $8.2M | ||
| Q4 24 | $2.1M | $22.9M | ||
| Q3 24 | $2.3M | $6.3M | ||
| Q2 24 | $21.5K | $5.4M | ||
| Q1 24 | $-814.6K | — |
| Q4 25 | 15.5% | 308.1% | ||
| Q3 25 | 31.9% | 5.1% | ||
| Q2 25 | 8.1% | 77.0% | ||
| Q1 25 | 11.2% | 69.1% | ||
| Q4 24 | 26.8% | 185.3% | ||
| Q3 24 | 27.9% | 60.4% | ||
| Q2 24 | 0.3% | 49.7% | ||
| Q1 24 | -10.4% | — |
| Q4 25 | 0.9% | 5.9% | ||
| Q3 25 | 0.5% | 3.2% | ||
| Q2 25 | 0.8% | 0.6% | ||
| Q1 25 | 0.8% | 0.8% | ||
| Q4 24 | 0.1% | 1.1% | ||
| Q3 24 | 2.3% | 0.3% | ||
| Q2 24 | 21.8% | 0.2% | ||
| Q1 24 | 5.8% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 3.38× | 0.10× | ||
| Q2 25 | 1.99× | 2.21× | ||
| Q1 25 | 3.37× | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | 2.32× | 1.82× | ||
| Q2 24 | 2.70× | 1.47× | ||
| Q1 24 | -0.64× | 9.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCEL
Segment breakdown not available.
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
